Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cost of Revenue: 2012-2020

Historic Cost of Revenue for Ironwood Pharmaceuticals (IRWD) over the last 9 years, with Dec 2020 value amounting to $3.1 million.

  • Ironwood Pharmaceuticals' Cost of Revenue fell 91.86% to $897,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $14.7 million, marking a year-over-year decrease of 38.62%. This contributed to the annual value of $3.1 million for FY2020, which is 86.86% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Cost of Revenue stood at $3.1 million for FY2020, which was down 86.86% from $23.9 million recorded in FY2019.
  • Over the past 5 years, Ironwood Pharmaceuticals' Cost of Revenue peaked at $32.8 million during FY2018, and registered a low of $1.9 million during FY2016.
  • For the 3-year period, Ironwood Pharmaceuticals' Cost of Revenue averaged around $19.9 million, with its median value being $23.9 million (2019).
  • In the last 5 years, Ironwood Pharmaceuticals' Cost of Revenue surged by 15,466.67% in 2016 and then plummeted by 86.86% in 2020.
  • Over the past 5 years, Ironwood Pharmaceuticals' Cost of Revenue (Yearly) stood at $1.9 million in 2016, then spiked by 922.32% to $19.1 million in 2017, then soared by 71.50% to $32.8 million in 2018, then fell by 27.10% to $23.9 million in 2019, then slumped by 86.86% to $3.1 million in 2020.